Windsor Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Windsor Financial Group's PFE Position: Q2 2017 in Review
Windsor Financial Group reduced its Pfizer (PFE) stake by 0.21% in Q2 2017, selling an estimated $8.45K and leaving 124,560 shares worth $3.97M. The position accounts for 1.85% of the portfolio, ranked #29.
Windsor Financial Group first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.65M in Q2 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Windsor Financial Group held 124,560 shares of Pfizer worth $3.97M as of Q2 2017.
- Windsor Financial Group sold 268 Pfizer shares in Q2 2017, an estimated $8.45K.
- Pfizer made up 1.85% of Windsor Financial Group's portfolio in Q2 2017, its #29 holding.
- Windsor Financial Group first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- Windsor Financial Group's Pfizer position peaked at $4.65M in Q2 2016.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Windsor Financial Group's 13F filing for Q2 2017, filed 3 Aug 2017.